reglab/housing_qa huggingface dataset:
LA Rev Stat § 40:1049.2 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1049.2. Legislative findings

RS 1049.2 - Legislative findings A. The Louisiana Legislature recognizes the devastating effect methamphetamine production has had on its citizens. B. Methamphetamine is unique in that it is a synthetic drug which can be produced by someone who does not possess specialized skill or training, is highly addictive, and can be made from inexpensive readily accessible ingredients. C. Methamphetamine has been reported as one of the most addictive and deadly drug threats in the United States. The use of methamphetamine can result in fatal kidney and lung disorders, brain damage, liver damage, chronic depression, psychosis, hallucinations, and many other devastating physical and mental effects. D. Louisiana has experienced a drop in methamphetamine production as restrictions on the sale of ephedrine, pseudoephedrine, and phenylpropanolamine have been implemented. E. Methamphetamine is not only deadly because of the devastating effects of drug addiction, but the production of methamphetamine has resulted in several laboratory explosions and the exposure of our citizens to death, injury, or toxic substances. F. While the production of methamphetamine has resulted in devastating effects on Louisiana citizens, the drugs used in making methamphetamine: ephedrine, pseudoephedrine, and phenylpropanolamine have legitimate medical uses. G. The Legislature of Louisiana hereby finds and declares that a pharmacist is in the unique position of dispensing nonprescription products containing ephedrine, pseudoephedrine, or phenylpropanolamine and interacting with the patient at the point of purchase of these products. This relationship with the consumer and the pharmacists' specialized knowledge about the pharmaceutical qualities of products containing ephedrine, pseudoephedrine, and phenylpropanolamine make the pharmacy the best location for the sale of those products to ensure the health and safety of Louisiana's citizens. H. The Louisiana Legislature, in enacting the provisions of this Part, seeks to provide for the legitimate medical needs of our citizens while at the same time protecting our citizens against the devastating effects of methamphetamines and methamphetamine production. I. In order to assist law enforcement and prosecutorial agencies in addressing the growing problems associated with methamphetamine production, a real time electronic database is needed to record purchases of products containing ephedrine, pseudoephedrine, and phenylpropanolamine at a pharmacy. J. Technology is available to record all purchases of products containing ephedrine, pseudoephedrine, and phenylpropanolamine at the point of sale and to transmit that information to a centralized location to be monitored and maintained in a central computer monitoring system operated by the Louisiana State Police. Acts 2009, No. 314, §1.
LA Rev Stat § 40:1049.4 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1049.4. Central computer monitoring system; system requirements

RS 1049.4 - Central computer monitoring system; system requirements A. In order to facilitate the monitoring of sales of nonprescription products containing ephedrine, pseudoephedrine, or phenylpropanolamine the pharmacist, certified pharmacy technician, or other pharmacy employee shall record all of the following information at the point of sale regarding the transaction: (1) The date of the transaction. (2) The name and address of the purchaser verified through photo identification of the purchaser as provided for in R.S. 40:1049.3(B)(1). (3) The name, quantity of packages, and total gram weight of the product or products purchased, received, or otherwise acquired. B. Upon recordation of the transaction information, the pharmacy shall transmit the information immediately to a central computer system for purposes of monitoring the sales of these products as provided for in this Section. C. The central computer system authorized by the provisions of this Section shall be designed and operated to allow the monitoring and reading of sales information regarding products containing ephedrine, pseudoephedrine, and phenylpropanolamine at the point of sale instantly and on a real-time basis. D. The central computer system authorized by the provisions of this Section shall be located within and administered by the Department of Public Safety and Corrections, office of state police. E. The central computer monitoring system shall provide for the monitoring of sales of compounds containing ephedrine, pseudoephedrine, and phenylpropanolamine and shall be capable of providing an online computer alert, to ensure direct scrutiny of conditions which would violate the provisions of this Part by law enforcement. F. The provisions of this Part shall not be construed to require that any pharmacy maintain the transaction records required under the provisions of this Part separate from the log book that is required under 21 U.S.C. 830(e). Use of the central computer monitoring system as required by this Part shall be deemed to satisfy both of these purposes. Acts 2009, No. 314, §1.
LA Rev Stat § 40:1049.5 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1049.5. Funding sources; no fees on pharmacists or pharmacies

RS 1049.5 - Funding sources; no fees on pharmacists or pharmacies A. Funding for the acquisition, implementation, and operation of the central computer monitoring system shall be funded through appropriation, gifts, grants, donations, or any other funding sources not otherwise prohibited by law. B. Thereafter, the maintenance of the central computer monitoring system shall be funded through appropriation, gifts, grants, donations, or any other funding sources not otherwise prohibited by law. C. The Department of Public Safety and Corrections, office of state police, and the Louisiana Sheriffs' Association may actively seek gifts, grants, and donations that may be available through the federal government or other sources to help fund the central computer monitoring system, provided that such gifts, grants, and donations are not otherwise prohibited by law or rule. D. No fee shall be charged to any pharmacist or pharmacy to defray the costs of acquiring, implementing, or maintaining the central computer monitoring system as authorized by the provisions of this Part, nor shall any fee be charged to any pharmacist or pharmacy for the transmission of information to the central computer monitoring system. Acts 2009, No. 314, §1.
LA Rev Stat § 40:1049.6 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1049.6. Shared information; state police; sheriffs

RS 1049.6 - Shared information; state police; sheriffs A. The Department of Public Safety and Corrections, office of state police shall share the information regarding the sale of products containing ephedrine, pseudoephedrine, or phenylpropanolamine as authorized by the provisions of this Part and provide instant access to the Louisiana Sheriffs' Association. B. The Department of Public Safety and Corrections, office of state police, is authorized to enter into a cooperative endeavor, memorandum of understanding, contract, or any other agreement with the Louisiana Sheriffs' Association, or any other law enforcement agency in order to share the information regarding the sale of products containing ephedrine, pseudoephedrine, or phenylpropanolamine as authorized by the provisions of this Part and to provide instant access to all appropriate law enforcement agencies. Acts 2009, No. 314, §1.
LA Rev Stat § 40:1049.7 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1049.7. Board of pharmacy access to information

RS 1049.7 - Board of pharmacy access to information  The Department of Public Safety and Corrections, office of state police, shall provide access to the information regarding the sale of products containing ephedrine, pseudoephedrine, or phenylpropanolamine as authorized by the provisions of this Part to the Louisiana Board of Pharmacy.  Acts 2009, No. 314, §1; Acts 2018, No. 206, §4.
LA Rev Stat § 40:1049.8 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1049.8. Pharmacists, certified pharmacy technician, or pharmacy employee not required to stop sale; may report

RS 1049.8 - Pharmacists, certified pharmacy technician, or pharmacy employee not required to stop sale; may report A.(1) The provisions of this Part shall not be construed to require a pharmacist, certified pharmacy technician, or pharmacy employee to prohibit or complete a sale of a product containing ephedrine, pseudoephedrine, or phenylpropanolamine even if the pharmacist, certified pharmacy technician, or other employee observes a warning or signal from the central computer monitoring program which indicates that the purchaser has purchased those products in amounts which exceed the amount which can be purchased by law. (2) The provisions of this Part shall not be construed to limit a pharmacist's professional judgment as otherwise provided for by law or rules adopted by the Louisiana Board of Pharmacy. B. A pharmacist, certified pharmacy technician, or pharmacy employee may report suspected violations of this Section or any other law to any local, state, or federal law enforcement agency, or the appropriate prosecutorial agency for further investigation or prosecution. C. No pharmacist, certified pharmacy technician, or pharmacy employee who in good faith reports suspected violations as provided for in this Part shall be liable to any person or entity for any claim of damages as a result of the act of reporting the information, and no lawsuit may be predicated thereon. Acts 2009, No. 314, §1.
LA Rev Stat § 40:1049.9 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1049.9. Licensed practitioner with prescriptive authority exempted

RS 1049.9 - Licensed practitioner with prescriptive authority exempted A health care practitioner with prescriptive authority who is licensed in the state of Louisiana shall be exempt from the requirements of the provisions of this Part in dispensing any product containing ephedrine, pseudoephedrine, or phenylpropanolamine to his patient. Acts 2009, No. 314, §1.
LA Rev Stat § 40:1049.10 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1049.10. Transmission of information contingent on functionality of central computer monitoring system

RS 1049.10 - Transmission of information contingent on functionality of central computer monitoring system A. The transmittal of transaction information of products containing ephedrine, pseudoephedrine, and phenylpropanolamine as authorized by the provisions of this Part is contingent upon the acquisition, implementation, and operation of the central computer monitoring system. B. No licensed pharmacist, certified pharmacy technician, or pharmacy employee at a pharmacy located in Louisiana and permitted by the Louisiana Board of Pharmacy shall be required to transmit data to the central computer monitoring system until the funding for the acquisition and implementation of the central computer monitoring system has been secured through appropriation, gifts, grants, donations, or any other funding sources not otherwise prohibited by law. C. No pharmacy, licensed pharmacist, certified pharmacy technician, or pharmacy employee at a pharmacy located in Louisiana and permitted by the Louisiana Board of Pharmacy shall be held responsible for failure to transmit transaction information as required by this Part if at any time the central computer monitoring system is rendered inoperable due to natural disaster, tampering, or any other reason. Acts 2009, No. 314, §1.
LA Rev Stat § 40:1049.11 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1049.11. Limitation of liability

RS 1049.11 - Limitation of liability A. The owner or operator of a retail pharmacy, who has submitted to the United States Attorney General a self-certification in accordance with the requirements of 21 U.S.C. 830(e) regarding training of employees engaged in the sale of products containing ephedrine, pseudoephedrine, or phenylpropanolamine shall not be liable for violations of this Part by the retail pharmacy's employees. B. No licensed pharmacist, certified pharmacy technician, or pharmacy employee at a pharmacy located in Louisiana and permitted by the Louisiana Board of Pharmacy shall be personally liable for any act or omission resulting in damage, injury, or loss arising out of the dispensing of a compound containing ephedrine, pseudoephedrine, or phenylpropanolamine and the transmittal of that transaction to the central computer monitoring program as authorized by the provisions of this Part; however, this limitation of liability shall not be applicable if the damage, injury, or loss was caused by the gross negligence or willful or wanton misconduct of the pharmacist, certified pharmacy technician, or pharmacy employee. Acts 2009, No. 314, §1.
LA Rev Stat § 40:1051 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1051. Commission created; membership; tenure; vacancies

RS 1051 - Commission created; membership; tenure; vacancies A. There is hereby created the Louisiana Narcotics Rehabilitation Commission to consist of five members appointed by the governor, by and with the advice and consent of the Senate, in the following manner. (1) The governor shall appoint two members from a list of four nominees submitted to him by the head of the Louisiana State University Health Sciences Center. (2) He shall appoint two members from a list of four nominees submitted to him by the head of the Tulane University School of Medicine. (3) He shall appoint one member from a list of two nominees submitted by the president of Loyola University. B. Insofar as practicable, the nominees shall possess broad knowledge and experience in medicine, psychology, social work, sociology, education or law. The governor shall designate one of the members of the commission to serve as chairman thereof. C. The term of office of each member of the commission shall be for five years; provided that the members first appointed shall serve for terms of one, two, three, four and five years, respectively, from January first next succeeding their appointment, and provided further that any member appointed to fill a vacancy occurring otherwise than by expiration of term shall be appointed for the remainder of the unexpired term of the member whom he is to succeed. Acts 1968, No. 575, §1; Acts 1999, No. 802, §5, eff. July 2, 1999.
LA Rev Stat § 40:1052 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1052. Development of services and facilities; pilot programs

RS 1052 - Development of services and facilities; pilot programs  The commission shall survey and analyze the problems of drug addiction within the state and shall formulate a comprehensive plan for the long range development, through the utilization of federal, state, local and private resources, of adequate services and facilities for the prevention and control of narcotic addiction and the diagnosis, treatment and rehabilitation of narcotic addicts, and from time to time revise such plan. It is authorized to establish, direct and carry on experimental pilot clinic programs for the treatment and rehabilitation of narcotic addicts, and from time to time revise such plan. It is authorized to establish, direct and carry on experimental pilot clinic programs for the treatment and rehabilitation of narcotic addicts, which programs may include the administration, under medical supervision and control, of methadone or other drugs as a substitute for narcotic or addictive drugs. In addition, the commission shall establish and maintain a program of detoxifications for persons in methadone clinics throughout the state; provided, however, that the detoxification period for all persons addicted to any drug, including methadone, shall not exceed fifteen months. After such period of time the effect of detoxification shall be assessed and the patient may be returned to the program if such period of time has not proven sufficient to achieve the desired results.  Acts 1968, No. 575, §2. Amended by Acts 1972, No. 358, §1.
LA Rev Stat § 40:1053 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1053. Donations or grants; personnel

RS 1053 - Donations or grants; personnel  The commission may receive donations or grants in furtherance of the performance of its duties. From such funds as may be available to it, including such appropriations as may be made thereto by the legislature, the commission may employ necessary personnel, fix their duties and compensation, and may provide for the compensation and reimbursement of expenses of members of the commission.  Acts 1968, No. 575, §3.
LA Rev Stat § 40:1054 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1054. Educational and training materials; records

RS 1054 - Educational and training materials; records  The commission shall gather and disseminate information and educational and training materials, and may maintain statistical and other records relating to narcotic addicts and addiction.  Acts 1968, No. 575, §4.
LA Rev Stat § 40:1055 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1055. Cooperation

RS 1055 - Cooperation  The state Board of Health, the state Department of Hospitals, the state Department of Institutions, the state Department of Public Welfare, and all other state and local agencies having any information pertaining to, jurisdiction over, or facilities available for narcotic addicts shall cooperate and assist the commission in the fulfillment of its powers and duties pursuant to this Subpart, and they may render such services to the commission within their respective functions as the commission may reasonably request.  Acts 1968, No. 575, §5.
LA Rev Stat § 40:1056 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1056. Repealed by Acts 1978, No. 786, §7, eff. July 17, 1978

RS 1056 - Repealed by Acts 1978, No. 786, §7, eff. July 17, 1978
LA Rev Stat § 40:1057 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1057. Title

RS 1057 - Title  This Part may be cited as the "State Hazardous Aerosol Act."  Added by Acts 1975, No. 590, §1, eff. July 17, 1975.
LA Rev Stat § 40:1057.2 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1057.2. Regulations declaring aerosol products; variations and exemptions; judicial review of determinations

RS 1057.2 - Regulations declaring aerosol products; variations and exemptions; judicial review of determinations  A. Whenever in the judgment of the secretary such action will promote the objectives of this Chapter by avoiding or resolving uncertainty as to its application, the secretary may by regulation declare such aerosol product to be a hazardous aerosol, for the purposes of this Chapter.  B. If the secretary finds that the requirements of R.S. 40:1057.1(11) or R.S. 40:1057.3(a) are not adequate for the protection of the public health and safety in view of the special hazard presented by any particular hazardous aerosol, he may by regulation establish such reasonable variations or additional label requirements as he finds necessary for the protection of the public health and safety, and any such hazardous aerosol product intended or packaged in a form suitable for use in the household or by children, which fails to bear a label in accordance with such regulations, shall be deemed to be a misbranded hazardous aerosol.  C. If the secretary finds that, because of the size of the package involved or because of the minor hazard presented by the substance contained therein or for other good and sufficient reasons, full compliance with the labeling requirements otherwise applicable under this Part is impracticable or is not necessary for the adequate protection of the public health and safety, the secretary shall promulgate regulations exempting such substance from these requirements to the extent he determines to be consistent with adequate protection of the public health and safety.  D. If the secretary finds that the hazard of an article subject to this Chapter is such that labeling adequate to protect the public health and safety cannot be devised or that the article presents an imminent danger to the public health and safety, the secretary may declare such article to be a banned hazardous aerosol and require its removal from commerce. Added by Acts 1975, No. 590, §1, eff. July 17, 1975. Amended by Acts 1978, No. 786, §5, eff. July 17, 1978.
LA Rev Stat § 40:1057.3 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1057.3. Regulations on aerosols; warnings; mandatory reporting

RS 1057.3 - Regulations on aerosols; warnings; mandatory reporting   A. Any warning on aerosol products shall be prominently located in relation to the brand name and shall be displayed in bold type. In addition, all ingredients must be listed in bold type.   B. All manufacturers of aerosol products containing toxic substances or which shall have fatal warnings on the containers shall file the proper treatment in case of misuse with the department. The department shall be responsible for compiling a list of such treatments and forwarding such list on a periodic basis as determined by the secretary to the Louisiana State Medical Society for review, and then distribution to all poison centers and other medical personnel and emergency treatment centers who may have cause to use such treatment.   C. Mandatory reporting of accidental or deliberate use causing injury and/or sudden deaths by involvement with aerosol products shall be required of physicians and coroners. Such reports shall be made directly to the office of health services and environmental quality of the Louisiana Department of Health. The department is directed to:   (1) Establish the necessary operations to receive statistics of use causing injury or deaths by aerosols.   (2) Forward statistical information to the Department of Education and other specified agencies on a quarterly basis.   (3) Direct coroners or pathologists who perform autopsies to be cognizant of the possible involvement of aerosols in the case being examined and particularly in the sudden death of youths.   Added by Acts 1975, No. 590, §1, eff. July 17, 1975. Amended by Acts 1978, No. 786, §5, eff. July 17, 1978.